ED

Eric Dai

Investor at Dimension

San Francisco, California

Overview 

Eric Dai is an Investor at Dimension focused on Life Sciences and Technology in San Francisco, California. With a background in Biomedical Engineering and experience at top organizations like Andreessen Horowitz and the U.S. Department of Energy, Eric has excelled in roles ranging from Bio+Health Deal Analyst to Program Coordinator, showcasing his expertise in biotech and health IT sectors. Eric's career highlights include serving as a Bio+Health Deal Analyst at Andreessen Horowitz and founding Penn Bio Launch as Co-Managing Director, demonstrating his ability to excel in investment analysis and entrepreneurial ventures within the biotech industry.

Work Experience 

  • Investor

    2023 - Current

    Investing in founders pushing the frontier of tech and life sciences. Learn more at: https://www.dimensioncap.com

Dimension Capital is a venture capital firm that prefers to invest in various industries.

  • Bio+Health Deal Analyst

    2022 - 2023

    a16z Bio Fund IV $1.5B Vehicle for Early and Growth Stage Bio+Health Startups

Andreessen Horowitz is a stage-agnostic venture capital firm with assets under management across multiple funds.

  • PhD Student in Bioengineering, Mauck Lab

    2016 - 2022

    (On Leave) Stem Cell Mechanobiology/Engineering with Rob Mauck

  • Teaching Assistant

    2018 - 2021

    TA for MSE 496 Senior Design with Vanessa Chan TA for BE 306 Cellular Engineering with Daniel Hammer

  • Venture Associate

    2021 - 2022

    Petri is a new approach for funding formation-stage startups at the intersection of biology and engineering. Created by the leaders behind iconic companies like Twist Bioscience, Ginkgo Bioworks, Beyond Meat, Exact Sciences, and many more.

Co-founded with iconic bio entrepreneurs to fund formation-stage bioengineering companies.

  • Program Coordinator at the DOE Office of Technology Transitions

    2021 - 2022

    Cleantech Commercialization

US Department of Energy is a government administration that regulates energy policy, research, and development.

  • Biotech Correspondent

    2021 - 2022

    Reported on leading startups in mRNA engineering, nucleic acid delivery and more

  • Co-Founder, Co-Managing Director

    2021 - 2021

    Bio Launch supports venture formation from biotechnologies at the University of Pennsylvania, the Wistar Institute, and CHOP. Merged into Nucleate to form Nucleate Philadelphia.

  • Head of Content & Community

    2020 - 2021

    Podcast, Articles, Community Engagement

  • Venture Fellow

    2020 - 2021

    Seed Stage Biotech VC

  • Campus Ambassador

    2020 - 2020

Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Drive Radical Advances in Human Health

  • Research Assistant

    2011 - 2012

    Particle Physics

Articles About Eric

Relevant Websites